Burmans plan Rs 925-crore healthcare fund

The Burman family, the promoters of major Dabur India, is planning to set up a $200 million (around Rs 925 crore) (PE) fund dedicated to the healthcare and life sciences segment.

This is the second major initiative of Burmans in the healthcare space after they sold their entire stake in cancer medicine manufacturing company Dabur Pharma for Rs 878 crore to French healthcare major Fresenius SE in 2008.

The Burmans are known to be investing in a greenfield facility to house the operations of Dabur Research Foundation, now a full-fledged contract research organization.

Former Dabur Pharma CEO will be heading the contract research entity as well as the private equity fund. When reached for comment, Vij confirmed the development.

Over the last few years, the Burmans have increased their interests in the financial sector space. At the start of the last decade, they set up a joint venture, Aviva Life Insurance, with the United Kingdom’s Aviva Group.

Gaurav Burman, who is former Chairman V C Burman’s younger son, is the Managing Partner of Elephant Capital, an AIM-listed private equity firm. Gaurav’s elder brother, Mohit Burman, who is a director on the Dabur India board, is the managing director of Elephant Capital, which has investments in East India Hotels, Mahindra Forgings, Nitco, Obopay and Global Cricket Ventures. Global Cricket Ventures, where Elephant invested in November 2009, is an online media and sports. Along with the Wadias of Bombay Dyeing and film actor Priety Zinta, Mohit Burman set up Kings XI Punjab, the Indian Premier League team.

Elephant Capital is a sector-agnostic firm focused on Indian companies, its website said. It looks at that have defensible strategies with some barriers to entry. Typically, it looks to invest US$10-20mn in a single transaction.

image
Business Standard
177 22
Business Standard

Burmans plan Rs 925-crore healthcare fund

BS Reporter  |  New Delhi 



The Burman family, the promoters of major Dabur India, is planning to set up a $200 million (around Rs 925 crore) (PE) fund dedicated to the healthcare and life sciences segment.

This is the second major initiative of Burmans in the healthcare space after they sold their entire stake in cancer medicine manufacturing company Dabur Pharma for Rs 878 crore to French healthcare major Fresenius SE in 2008.

The Burmans are known to be investing in a greenfield facility to house the operations of Dabur Research Foundation, now a full-fledged contract research organization.

Former Dabur Pharma CEO will be heading the contract research entity as well as the private equity fund. When reached for comment, Vij confirmed the development.

Over the last few years, the Burmans have increased their interests in the financial sector space. At the start of the last decade, they set up a joint venture, Aviva Life Insurance, with the United Kingdom’s Aviva Group.

Gaurav Burman, who is former Chairman V C Burman’s younger son, is the Managing Partner of Elephant Capital, an AIM-listed private equity firm. Gaurav’s elder brother, Mohit Burman, who is a director on the Dabur India board, is the managing director of Elephant Capital, which has investments in East India Hotels, Mahindra Forgings, Nitco, Obopay and Global Cricket Ventures. Global Cricket Ventures, where Elephant invested in November 2009, is an online media and sports. Along with the Wadias of Bombay Dyeing and film actor Priety Zinta, Mohit Burman set up Kings XI Punjab, the Indian Premier League team.

Elephant Capital is a sector-agnostic firm focused on Indian companies, its website said. It looks at that have defensible strategies with some barriers to entry. Typically, it looks to invest US$10-20mn in a single transaction.

RECOMMENDED FOR YOU

Burmans plan Rs 925-crore healthcare fund

The Burman family, the promoters of FMCG major Dabur India, is planning to set up a $200 million (around Rs 925 crore) private equity (PE) fund dedicated to the healthcare and life sciences segment.

The Burman family, the promoters of major Dabur India, is planning to set up a $200 million (around Rs 925 crore) (PE) fund dedicated to the healthcare and life sciences segment.

This is the second major initiative of Burmans in the healthcare space after they sold their entire stake in cancer medicine manufacturing company Dabur Pharma for Rs 878 crore to French healthcare major Fresenius SE in 2008.

The Burmans are known to be investing in a greenfield facility to house the operations of Dabur Research Foundation, now a full-fledged contract research organization.

Former Dabur Pharma CEO will be heading the contract research entity as well as the private equity fund. When reached for comment, Vij confirmed the development.

Over the last few years, the Burmans have increased their interests in the financial sector space. At the start of the last decade, they set up a joint venture, Aviva Life Insurance, with the United Kingdom’s Aviva Group.

Gaurav Burman, who is former Chairman V C Burman’s younger son, is the Managing Partner of Elephant Capital, an AIM-listed private equity firm. Gaurav’s elder brother, Mohit Burman, who is a director on the Dabur India board, is the managing director of Elephant Capital, which has investments in East India Hotels, Mahindra Forgings, Nitco, Obopay and Global Cricket Ventures. Global Cricket Ventures, where Elephant invested in November 2009, is an online media and sports. Along with the Wadias of Bombay Dyeing and film actor Priety Zinta, Mohit Burman set up Kings XI Punjab, the Indian Premier League team.

Elephant Capital is a sector-agnostic firm focused on Indian companies, its website said. It looks at that have defensible strategies with some barriers to entry. Typically, it looks to invest US$10-20mn in a single transaction.

image
Business Standard
177 22
Widgets Magazine

More News

Widgets Magazine
Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard